Skip to content

Radionuclidic and Non-radionuclidic Molecular Imaging Agents for Estrogen Receptor Based on 11-beta Substituted Steroidal Anti-Estrogens

A highly selective and stable molecular probe for diagnosis of estrogen-dependent diseases

Published: 9th March 2021
Radionuclidic and Non-radionuclidic Molecular Imaging Agents for Estrogen Receptor Based on 11-beta Substituted Steroidal Anti-Estrogens
Source: National Cancer Institute, unsplash.com/photos/SMxzEaidR20, Unsplash Licence
Patents
  • 10,246,414
IP Status
  • Patented
Seeking
  • Development partner
  • Commercial partner
  • Licensing